Recurrent or metastatic nasopharyngeal carcinoma is an aggressive disease, and long-term survival with chemotherapy alone is ...
The author cherishes family time during Thanksgiving and Christmas, despite undergoing cancer treatment. Chemotherapy and ...
Light the Night walk fosters community and remembrance for those affected by blood cancer, with symbolic lanterns for support ...
Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.
The U.S. Food and Drug Administration (FDA) has approved niraparib (Zejula) plus Akeega (abiraterone acetate) and prednisone ...
The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...
The YES intervention improved general and cancer-specific quality of life in AYA breast cancer survivors over six months.
Most premenopausal women with early breast cancer accepted GnRHa therapy during chemotherapy to preserve ovarian function, ...
High-dose radiation with Keytruda led to increased infiltration of various immune cells and formation of tertiary lymphoid ...
Accurate information about Lynch syndrome is essential. As more people discuss hereditary cancer online, misinformation ...
“In our real-world experience, [Yescarta] in relapsed or refractory follicular lymphoma showed durable responses and a ...
In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.